CVS Transplant Headline News News Icon
Today's Transplant Headlines

search

ProCare

Enroll In CVS ProCare

FREE Info Kit

Provide your confidential contact info and we will call your to answer your questions! Name:

Phone:

Best Time To Call:

A PharmaCare representative will call to assist you and answer your questions. We will leave a brief message if you are unavailable at the time of our call.


Pharmacy

Special Callout
Call Today
1-800-238-7828

Pharmacy


E-Mail this Article to a friend!Powered by ReutersPharmacy
Pharmacy

Lymphoid irradiation may reduce heart transplant-related atherosclerosis

Last Updated: 2001-04-30 9:59:48 EDT (Reuters Health)

By Joene Hendry

WESTPORT, CT (Reuters Health) - In a group of cardiac transplant patients, those treated with total lymphoid irradiation for repeat rejection episodes appear to develop less coronary atherosclerosis than those not treated, according to data presented Thursday at the International Society for Heart and Lung Transplantation meeting in Vancouver, Canada.

Dr. Marc P. Pelletier and colleagues at Stanford University in California conducted a retrospective analysis of post-transplant angiograms in a group of 31 cardiac transplant patients who required total lymphoid irradiation for persistent or recurrent allograft rejection. They compared these angiograms with those from a group of 32 cardiac transplant patients not treated with total lymphoid irradiation.

The patients were matched for donor and recipient gender, age, race, and CMV status at the time of transplant as well as induction and immunosuppressive therapy. The researchers report the study group had mean of 4.4 rejection episodes compared with 2.3 episodes for controls. Mean followup was 5.7 years for the study group and 6.9 years in controls.

"Despite more rejection episodes and despite a greater proportion of ischemic heart disease...only 8 of 31 patients in our study group developed any evidence of atherosclerosis on angiography testing, versus 19 of 32 in our control group," Dr. Pelletier told Reuters Health.

He said that, while the findings are interesting, "a randomized trial would be needed to provide conclusive results, but this patient population is very difficult to randomize."

Used mostly during the 1990s, total lymphoid irradiation has become less common with the development of new immunosuppressive drugs during the last few years, Dr. Pelletier noted. He added, however, that total lymphoid irradiation "is still a very nice therapy for patients undergoing repeat rejections."

-Westport Newsroom 203 319 2700


 
Pharmacy
 
Copyright 2001 Reuters Limited. All rights reserved. Republication or redistribution of Reuters Limited content, including by framing or similar means, is expressly prohibited without prior written consent of Reuters Limited. Reuters Limited shall not be liable for any error or delays in the content, or for any actions taken in reliance thereon.

Pharmacy Back To Transplant Wellness CenterPharmacy


CVS ProCare -Specialized Pharmacy CarePharmacyEnroll Today!

Home | Customer Care | Enrollment | Free Information Kit | Site Map | Privacy | Back to Top

A MEMBER OF THE CVS FAMILY OF CARE
 
© PharmaCare 2001 | Content Last Modified .